Inventor
MURUGESAN NATESAN
US43 patents
⚠️ This page may combine multiple inventors who share the name “MURUGESAN NATESAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
38 patentsUS5612359AMar 18, 1997
Substituted biphenyl isoxazole sulfonamides
BRISTOL MYERS SQUIBB CO533 citations99
US6043265AMar 28, 2000
Isoxazolyl endothelin antagonists
BRISTOL MYERS SQUIBB CO402 citations98
US5846990ADec 8, 1998
Substituted biphenyl isoxazole sulfonamides
BRISTOL MYERS SQUIBB CO132 citations98
US5760038AJun 2, 1998
Substituted biphenyl sulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO81 citations96
US5514696AMay 7, 1996
Phenyl sulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO92 citations96
US5378715AJan 3, 1995
Sulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO96 citations96
US6852745B2Feb 8, 2005
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
BRISTOL MYERS SQUIBB CO55 citations95
US6271248B1Aug 7, 2001
Substituted biphenysulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO30 citations93
US6080774AJun 27, 2000
Substituted biphenylsulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO37 citations93
US5939446AAug 17, 1999
Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO18 citations93
US7378418B2May 27, 2008
Azabicyclic heterocycles as cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO24 citations92
US6107320AAug 22, 2000
Phenyl sulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO21 citations92
US5846985ADec 8, 1998
Substituted biphenyl isoxazole sulfonamides
BRISTOL MYERS SQUIBB CO38 citations92
US5827869AOct 27, 1998
Substituted biphenyl isoxazole sulfonamides
BRISTOL MYERS SQUIBB CO22 citations92
US5780473AJul 14, 1998
Substituted biphenyl sulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO34 citations92
US5420123AMay 30, 1995
Dibenzodiazepine endothelin antagonists
BRISTOL MYERS SQUIBB CO38 citations92
US9790169B2Oct 17, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO19 citations91
US6638937B2Oct 28, 2003
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
BRISTOL MYERS SQUIBB CO26 citations91
US7884113B2Feb 8, 2011
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO8 citations83
US7452892B2Nov 18, 2008
Triazolopyrimidine cannabinoid receptor 1 antagonists
BRISTOL MYERS SQUIBB CO10 citations83
US12286428B2Apr 29, 2025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO2 citations74
US6673824B1Jan 6, 2004
Phenyl sulfonamide endothelin antagonists
BRISTOL MYERS SQUIBB CO11 citations74
US6835741B2Dec 28, 2004
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
BRISTOL MYERS SQUIBB CO10 citations72
US10167254B2Jan 1, 2019
IDO inhibitors
BRISTOL MYERS SQUIBB CO1 citations71
US9657009B2May 23, 2017
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO4 citations71
US9546153B2Jan 17, 2017
Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO5 citations71
US9169252B2Oct 27, 2015
Heteroaryl substituted nicotinamide compounds
BRISTOL MYERS SQUIBB CO5 citations71
US7157461B2Jan 2, 2007
Substituted dihydropyrimidine inhibitors of calcium channel function
BRISTOL MYERS SQUIBB CO9 citations70
US7816357B2Oct 19, 2010
Azabicyclic heterocycles as cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO2 citations62
US10544133B2Jan 28, 2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations52
US7709647B2May 4, 2010
Tetrahydroquinoline cannabinoid receptor modulators
BRISTOL MYERS SQUIBB CO1 citations52
US7572808B2Aug 11, 2009
Triazolopyridine cannabinoid receptor 1 antagonists
BRISTOL MYERS SQUIBB CO1 citations52
US12269819B2Apr 8, 2025
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO0 citations51
US10023562B2Jul 17, 2018
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations51
US7754755B2Jul 13, 2010
Inhibitors of 15-lipoxygenase
BRISTOL MYERS SQUIBB CO1 citations47
US7166603B2Jan 23, 2007
Dihydropyrimidone inhibitors of calcium channel function
BRISTOL MYERS SQUIBB CO0 citations40
US10618903B2Apr 14, 2020
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO0 citations39
US10562887B2Feb 18, 2020
Triazolones and tetrazolones as inhibitors of ROCK
BRISTOL MYERS SQUIBB CO0 citations34